by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersMaria E. De La Torre Silva, M.D.

All Warning Letters

Maria E. De La Torre Silva, M.D.

Warning LetterOpen

Maria E. De La Torre Silva, M.D., 27327 SW 133rd Court Homestead , FL 33032 United StatesIssued Jul 27, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations2

Issue DateJul 27, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Maria E. De La Torre Silva, M.D.
Location: Maria E. De La Torre Silva, M.D., 27327 SW 133rd Court Homestead , FL 33032 United States
FEI Number: N/A
Country: United States
Issue Date: July 27, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Clinical Investigator

Maria E. De La Torre Silva, M.D. FDA Warning Letter, July 27, 2026